Stocks LLY

Bernstein Maintains Eli Lilly and (LLY) Outperform Recommendation

Fintel reports that on November 24, 2025, Bernstein maintained coverage of Eli Lilly and (NYSE:LLY) with a Outperform recommendation.

Analyst Price Forecast Suggests 3.66% Downside

As of November 17, 2025, the average one-year price target for Eli Lilly and is $1,020.92/share. The forecasts range from a low of $713.10 to a high of $1,575.00. The average price target represents a decrease of 3.66% from its latest reported closing price of $1,059.70 / share.

See our leaderboard of companies with the largest price target upside.

The projected annual revenue for Eli Lilly and is 37,840MM, a decrease of 36.32%. The projected annual non-GAAP EPS is 15.45.

What is the Fund Sentiment?

There are 5,583 funds or institutions reporting positions in Eli Lilly and. This is unchanged over the last quarter. Average portfolio weight of all funds dedicated to LLY is 0.95%, an increase of 10.95%. Total shares owned by institutions decreased in the last three months by 3.27% to 875,419K shares. LLY / Eli Lilly and Company Put/Call Ratios The put/call ratio of LLY is 0.84, indicating a bullish outlook.

What are Other Shareholders Doing?

Lilly Endowment holds 95,493K shares representing 10.67% ownership of the company. In its prior filing, the firm reported owning 96,017K shares , representing a decrease of 0.55%.

Pnc Financial Services Group holds 51,364K shares representing 5.74% ownership of the company. In its prior filing, the firm reported owning 51,294K shares , representing an increase of 0.14%. The firm decreased its portfolio allocation in LLY by 85.40% over the last quarter.

VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 27,429K shares representing 3.06% ownership of the company. In its prior filing, the firm reported owning 26,960K shares , representing an increase of 1.71%. The firm decreased its portfolio allocation in LLY by 14.32% over the last quarter.

Capital Research Global Investors holds 25,088K shares representing 2.80% ownership of the company. In its prior filing, the firm reported owning 20,756K shares , representing an increase of 17.27%. The firm increased its portfolio allocation in LLY by 10.87% over the last quarter.

VFINX - Vanguard 500 Index Fund Investor Shares holds 22,328K shares representing 2.49% ownership of the company. In its prior filing, the firm reported owning 21,893K shares , representing an increase of 1.95%. The firm decreased its portfolio allocation in LLY by 14.48% over the last quarter.

Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.

Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.

Click to Learn More

This story originally appeared on Fintel.

Fintel
Fintel is a leading provider of financial data and insights for intelligent, data-driven investors. With coverage of over 75,000 listed companies on all major stock exchanges, Fintel has the most comprehensive coverage of global equities at prices individual investors can afford.
Check out our Unique Analysis of Insider Sentiment for Eli Lilly and Company Find out what the Options Markets think of Eli Lilly and Company See our take on Eli Lilly and Company Upcoming Earnings More articles by this source

Tags

Stocks Mentioned

Latest Articles

Data is currently not available